glucagon has been researched along with fructosamine in 10 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (fructosamine) | Trials (fructosamine) | Recent Studies (post-2010) (fructosamine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 1,592 | 202 | 344 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maezawa, H; Sugiyama, H; Uchimura, I; Watanabe, T | 1 |
| Aperia, A; Dahlqvist, G; Efendic, S; Lindblad, BS; Persson, B; Rudberg, S; Skottner, A | 1 |
| Anastasio, P; Capasso, G; Capodicasa, G; Castellino, P; Coppola, S; De Santo, NG; Giordano, C; Perna, A; Salvatore, T; Torella, R | 1 |
| Johansson, BL; Kernell, A; Sjöberg, S; Wahren, J | 1 |
| De Paepe, M; Gorus, F; Keymeulen, B; Klöppel, G; Korbutt, G; Pipeleers, DG | 1 |
| Anselmo, J; Keymeulen, B; Pipeleers, D | 1 |
| Chandran, M; Crean, J; Henry, RR; Kolterman, OG; Levetan, C; Maggs, DG; Mudaliar, SR; Strobel, SA; Wang, Y; Want, LL; Weyer, C | 1 |
| Ahlgren, KM; Fall, T; Holm, B; Kämpe, O; Karlsson, A; von Euler, H | 1 |
| Bronsvoort, BM; Evans, H; Handel, IG; Kovalik, M; Mellanby, RJ; Thoday, KL; van den Broek, AH | 1 |
| Clark, M; Hoenig, M; Reiche, D; Schaeffer, DJ | 1 |
3 trial(s) available for glucagon and fructosamine
| Article | Year |
|---|---|
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1.
Topics: Adolescent; Adult; Albuminuria; Blood Glucose; Blood-Retinal Barrier; C-Peptide; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fructosamine; Glomerular Filtration Rate; Glucagon; Glycated Hemoglobin; Growth Hormone; Hexosamines; Humans; Insulin; Insulin Infusion Systems; Kidney; Male; Norepinephrine; Pilot Projects | 1993 |
Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
Topics: Adult; Amyloid; Blood Glucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Islet Amyloid Polypeptide; Male; Middle Aged; Postprandial Period; Triglycerides | 2003 |
Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.
Topics: Animals; Blood Glucose; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Administration Schedule; Female; Fructosamine; Glucagon; Immunosuppressive Agents; Insulin; Male; Severity of Illness Index; Treatment Outcome | 2011 |
7 other study(ies) available for glucagon and fructosamine
| Article | Year |
|---|---|
Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fructosamine; Glucagon; Hexosamines; Humans; Hydroxybutyrates; Ketone Bodies; Kinetics; Male; Middle Aged; Regression Analysis | 1991 |
Indications that branched chain amino acids, in addition to glucagon, affect the glomerular filtration rate after a high protein diet in insulin-dependent diabetes.
Topics: Adolescent; Adult; Albuminuria; Amino Acids, Branched-Chain; Biomarkers; Blood Glucose; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 1; Dietary Proteins; Eating; Female; Fructosamine; Glomerular Filtration Rate; Glucagon; Growth Hormone; Hexosamines; Humans; Insulin-Like Growth Factor I; Male; Renal Circulation | 1991 |
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children.
Topics: Adolescent; Blood Glucose; Child; Diabetes Mellitus, Type 1; Dietary Proteins; Female; Fructosamine; Glomerular Filtration Rate; Glucagon; Hexosamines; Humans; Insulin; Male; Renal Circulation | 1989 |
Long-term metabolic control by rat islet grafts depends on the composition of the implant.
Topics: Aging; Animals; Blood Glucose; Cell Count; Diabetes Mellitus, Experimental; Fructosamine; Glucagon; Glucose Tolerance Test; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney; Liver; Male; Portal Vein; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Heterotopic | 1996 |
Length of metabolic normalization after rat islet cell transplantation depends on endocrine cell composition of graft and on donor age.
Topics: Age Factors; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fructosamine; Glucagon; Graft Survival; Insulin; Islets of Langerhans Transplantation; Liver; Male; Pancreas; Rats; Rats, Inbred Lew; Time Factors | 1997 |
Glucagon stimulation test for estimating endogenous insulin secretion in dogs.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Dog Diseases; Dogs; Female; Fructosamine; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Treatment Outcome | 2008 |
Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
Topics: 3-Hydroxybutyric Acid; Adiponectin; Animals; Cat Diseases; Cats; Diabetes Mellitus; Drinking; Electrolytes; Fatty Acids, Nonesterified; Female; Fructosamine; Glucagon; Glucose Tolerance Test; Glycosuria; Hypoglycemic Agents; Leptin; Male; Nitriles; Obesity; Sodium-Glucose Transporter 2 Inhibitors | 2018 |